LD-01

N/A

Report date: 2024/12/12 16:37:25

Base Information

Drug NameLD-01
Drug Alias NameLD-01
ClassificationBiologics
Mechanisms of ActionCytotoxic T-Lymphocyte-Associated Antigen 4 inhibitorsProgrammed cell death protein 1 blockers
TargetsCytotoxic T-Lymphocyte-Associated Antigen 4Programmed cell death protein 1
Therapy Area/IndicationsNeoplasmsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLeidos
China Registration ClassN/A

Develop Information

Active CompaniesLeidos
Inactive CompaniesN/A
Active IndicationsNeoplasmsMalaria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A